Summary
Arbidol, ethyl-6-bromo-4-[(dimethylamino)-methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-in dole-3-carboxylate hydrochloride monohydrate, is an antiviral chemical agent. In this report, we studied the antiviral activity of arbidol against a panel of human respiratory viruses, namely influenza A virus (FLU-A, A/PR/8/34 H1N1), respiratory syncytial virus (RSV), human rhinovirus type 14 (HRV 14), coxsackie virus B3 (CVB3) and adenovirus type 7 (AdV-7) in vitro in cell culture. Arbidol was found to present potent inhibitory activity against enveloped and non-enveloped RNA viruses, including FLU-A, RSV, HRV 14 and CVB3 when added before, during, or after viral infection, with 50% inhibitory concentration (IC50) ranging from 2.7 to 13.8 µg/ml. However, arbidol showed selective antiviral activity against AdV-7, a DNA virus, only when added after infection (therapeutic index (TI) = 5.5). Orally administered arbidol at 50 or 100 mg/kg/day beginning 24 h pre-virus exposure for 6 days significantly reduced mean pulmonary virus yields and the rate of mortality in mice infected with FLU-A (A/PR/8/34 H1N1). Our results suggest that arbidol has the ability to elicit protective broad-spectrum antiviral activity against a number of human pathogenic respiratory viruses.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anonymous (1999) ArticleTitleArbidol Drugs R&D 2 171–172
YS Boriskin EI Pecheur SJ Polyak (2006) ArticleTitleArbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection Virol J 3 56 Occurrence Handle16854226 Occurrence Handle10.1186/1743-422X-3-56
MJ Brooks JJ Sasadeusz GA Tannock (2004) ArticleTitleAntiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline? Pulmonary Med 10 197–203 Occurrence Handle10.1097/00063198-200405000-00009 Occurrence Handle1:CAS:528:DC%2BD2cXktl2mu74%3D
RA Burger JL Billingsley JH Huffman KW Bailey CU Kim (2000) ArticleTitleImmunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice Immunopharmacology 47 45–52 Occurrence Handle10708809 Occurrence Handle10.1016/S0162-3109(99)00184-8 Occurrence Handle1:CAS:528:DC%2BD3cXhsFOhtLY%3D
H Chai Y Zhao C Zhao P Gong (2006) ArticleTitleSynthesis and in vitro anti-hepatitis B virus activities of some ethyl-6-bromo-5-hydroxy-1H-indole-3-carboxylates Bioorg Med Chem 14 911–917 Occurrence Handle16183290 Occurrence Handle10.1016/j.bmc.2005.08.041 Occurrence Handle1:CAS:528:DC%2BD28XhvFOisw%3D%3D
IT Fedyakina IA Lenyova SS Yamnikova RG Glushkov (2005) ArticleTitleSensitivity of influenza A/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells Vopr Virusol 50 32–35 Occurrence Handle1:CAS:528:DC%2BD28XmsVWkuw%3D%3D
DM Fleming KW Cross (1993) ArticleTitleRespiratory syncytial virus or influenza Lancet 324 1507–1510 Occurrence Handle10.1016/S0140-6736(05)80082-0
A Garozzo CC Cutri A Castro G Tempera F Guerrera MC Sarva E Geremia (2000) ArticleTitleAnti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives Antiviral Res 45 199–210 Occurrence Handle10771083 Occurrence Handle10.1016/S0166-3542(00)00072-3 Occurrence Handle1:CAS:528:DC%2BD3cXisFGrsrk%3D
JE Gern WW Busse (1999) ArticleTitleAssociation of rhinovirus infections with asthma Clin Microbiol Rev 12 9–18 Occurrence Handle9880472 Occurrence Handle1:STN:280:DyaK1M7itlSltA%3D%3D
TA Guskova IA Leneva IT Fedyakina VV Chistyakov RG Glushkov (1999) ArticleTitleArbidol kinetics and its effect on influenza A virus replication in MDCK cell culture Chemico Pharmaceut J 6 14–17
FG Hayden RL Atmar M Schilling C Johnson D Poretz D Paar L Huson P Ward RG Mills (1999) ArticleTitleUse of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza N Engl J Med 341 1336–1343 Occurrence Handle10536125 Occurrence Handle10.1056/NEJM199910283411802 Occurrence Handle1:CAS:528:DyaK1MXnsVeitbc%3D
FG Hayden RB Belshe C Villaneueva R Lanno C Hughes I Small R Dutkowski P Ward J Carr (2004) ArticleTitleManagement of influenza in households: a prospective randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis J Infect Dis 189 440–449 Occurrence Handle14745701 Occurrence Handle10.1086/381128 Occurrence Handle1:CAS:528:DC%2BD2cXhvFSgtbg%3D
L Kaiser C Wat T Mills P Mahoney P Ward F Hayden (2003) ArticleTitleImpact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations Arch Intern Med 163 1667–1672 Occurrence Handle12885681 Occurrence Handle10.1001/archinte.163.14.1667 Occurrence Handle1:CAS:528:DC%2BD3sXmsV2lsrg%3D
M Kiso K Mitamura Y Sakai-Tagawa K Shiraishi C Kawakami K Kimura F Hayden N Sugaya Y Kawaoka (2004) ArticleTitleResistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 759–765 Occurrence Handle15337401 Occurrence Handle10.1016/S0140-6736(04)16934-1 Occurrence Handle1:CAS:528:DC%2BD2cXntVOjt7Y%3D
MCJ Kneyber HA Moll RD Groot (2000) ArticleTitleTreatment and prevention of respiratory syncytial virus infection Eur J Pediatr 159 399–411 Occurrence Handle10867843 Occurrence Handle10.1007/s004310051296 Occurrence Handle1:STN:280:DC%2BD3M%2FhsFartw%3D%3D
Leneva IA, Fedyakina IT, Fadeeva NI, Guskova TA (1996) Effect of a new antiviral drug arbidol on influenza virus replication. Xth International Congress of Virology Aug: 11–16
IA Leneva A Hay (1998) ArticleTitleThe mechanism of action of arbidol against influenza virus: selection and characterization of arbidol-resistant mutants Antiviral Res 37 89
Yaolan Li PH Paul (2005) ArticleTitleAntiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Fordin Antiviral Res 68 1–9 Occurrence Handle16140400 Occurrence Handle10.1016/j.antiviral.2005.06.004 Occurrence Handle1:CAS:528:DC%2BD2MXhtVarsbbK
RS Maitreyi S Broor SK Kabra (2000) ArticleTitleRapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections J Clin Virol 16 41–47 Occurrence Handle10680739 Occurrence Handle10.1016/S1386-6532(99)00075-X Occurrence Handle1:CAS:528:DC%2BD3cXosFWmtA%3D%3D
W Markland TJ Mcquaid J Jain AD Kwong (2000) ArticleTitleBroad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon Antimicro Agents Chemother 44 859–866 Occurrence Handle10.1128/AAC.44.4.859-866.2000 Occurrence Handle1:CAS:528:DC%2BD3cXitFOltb0%3D
NJ Marshall CJ Goodwin SJ Holt (1995) ArticleTitleA critical assessement of the use of microculture tetrazolium assays to measure cell growth and function Growth Regulation 5 69–84 Occurrence Handle7627094 Occurrence Handle1:CAS:528:DyaK2MXmslCrtLs%3D
H Monobe T Ishibashi Y Nomura M Shinogami J Yano (2003) ArticleTitleRole of respiratory viruses in children with acute otitis media Int J Pediatr Otorhinolaryngol 67 801–806 Occurrence Handle12791457 Occurrence Handle10.1016/S0165-5876(03)00124-1
T Mosmann (1983) ArticleTitleRapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays J Immunol Methods 65 55–63 Occurrence Handle6606682 Occurrence Handle10.1016/0022-1759(83)90303-4 Occurrence Handle1:STN:280:BiuD1cbgsFE%3D
FM Munoz GJ Galasso JM Gwaltney FG Hayden B Murphy R Webster P Wright RB Couch (2000) ArticleTitleCurrent research on influenza and other respiratory viruses: II. International Symposium Antiviral Res 46 91–124 Occurrence Handle10854663 Occurrence Handle10.1016/S0166-3542(00)00092-9 Occurrence Handle1:CAS:528:DC%2BD3cXktVSnurs%3D
NG Papadopoulos PJ Bates PG Bardin A Papi SH Leir DJ Fraenkel (2000) ArticleTitleRhinoviruses infect the lower airways J Infect Dis 181 1875–1884 Occurrence Handle10837165 Occurrence Handle10.1086/315513 Occurrence Handle1:STN:280:DC%2BD3c3pvV2jug%3D%3D
DD Patel A Kapoor A Ayyagari TN Dhole (2004) ArticleTitleDevelopment of a simple restriction fragment length polymorphism assay for subtyping of coxsackie B viruses J Virol Methods 120 167–172 Occurrence Handle15288959 Occurrence Handle10.1016/j.jviromet.2004.05.001 Occurrence Handle1:CAS:528:DC%2BD2cXmt1Wktb8%3D
LJ Reed HA Muench (1938) ArticleTitleA simple method of estimating fifty percent endpoints Am J Hyg 27 493–497
J Schulman (1968) ArticleTitleEffect of L-amantanamine hydrochloride(amantadine HCL) and methyl-L-adamantanethylamine hydrochloride (rimantadine HCL) on teansmission of influenza virus infection in mice Proc Soc Exp Biol Med 128 1173–1178 Occurrence Handle1:CAS:528:DyaF1cXltVCksLc%3D
K Sudo Y Miyazaki N Kojima M Kobayashi H Suzuki M Shintani Y Shimizu (2005) ArticleTitleYM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action Antiviral Res 65 125–131 Occurrence Handle15708639 Occurrence Handle10.1016/j.antiviral.2004.12.002 Occurrence Handle1:CAS:528:DC%2BD2MXhtlSlsLY%3D
WW Thompson DK Shay E Weintraub L Brammer N Cox LJ Anderson K Fukuda (2003) ArticleTitleMortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 179–186 Occurrence Handle12517228 Occurrence Handle10.1001/jama.289.2.179
World Health Organization (WHO) (2004) World Health Organization: Influenza. http://www.who.int/mediacentre/factsheets/2003/fs211/en/
PR Wyde (1998) ArticleTitleRespiratory syncytial virus (RSV) disease and prospects for its control Antiviral Res 39 63–79 Occurrence Handle9806484 Occurrence Handle10.1016/S0166-3542(98)00029-1 Occurrence Handle1:CAS:528:DyaK1cXmt1entLk%3D
X Xiang D Qiu KP Chan SH Chan RG Hegele WC Tan (2002) ArticleTitleComparison of three methods for respiratory virus detection between induced sputum and nasopharyngeal aspirate specimens in acute asthma J Virol Methods 101 127–133 Occurrence Handle11849691 Occurrence Handle10.1016/S0166-0934(01)00431-1 Occurrence Handle1:CAS:528:DC%2BD38Xht1ahur4%3D
VV Zarubaev AV Slita VZ Krivitskaya AK Sirotkin AL Kovalenko NK Chatterjee (2003) ArticleTitleDirect antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro Antiviral Res 58 131–137 Occurrence Handle12742573 Occurrence Handle10.1016/S0166-3542(02)00193-6 Occurrence Handle1:CAS:528:DC%2BD3sXjs1CrtbY%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shi, L., Xiong, H., He, J. et al. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo . Arch Virol 152, 1447–1455 (2007). https://doi.org/10.1007/s00705-007-0974-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-007-0974-5